Skip to main content
SpringerLink
Log in

Timing of Vaccinations in Premature Infants

  • Review Article
  • Published:
BioDrugs Aims and scope Submit manuscript

Abstract

Preterm infants have immunological immaturities that may impact on vaccine responses. Larger premature infants mount immune responses to vaccines that are similar to those of full term infants, but very premature infants (<30 weeks’ gestation at birth) have specific defects in vaccine responsiveness. The immunogenicity of diphtheria, tetanus and pertussis antigens is similar in full term and premature infants. Poliovirus vaccines, however, do not always stimulate adequate antibody responses in premature infants. The immunogenicity of Haemophilus influenzae type b conjugate vaccines varies widely in studies of premature infants, and may be affected both by choice of conjugate protein and by the infant’s overall health. Hepatitis B vaccine given at birth appears poorly immunogenic in infants with birthweights <1750g, with delay in the administration of the first dose yielding improved immunogenicity. Sick premature infants may suffer increased episodes of apnoea following vaccine administration. Persistence of immunity, the quality of the immune response, and evaluation of the specific tolerability and immunogenicity of new vaccines in premature infants are topics needing further research. Although it is generally true that recommendations for vaccination of term infants are applicable to premature infants, it is not always specifically true. Optimal care of preterm infants requires attention to the exceptions to this generalisation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Committee on Infectious Diseases, American Academy of Pediatrics. Immunization in special circumstances. In: Peter G, editor. 1997 Red book: report of the committee on infectious diseases. 24th ed. Elk Grove Village (IL): American Academy of Pediatrics, 1997: 48

    Google Scholar 

  2. Siegrist CA. Vaccination strategies for children with specific medical conditions: a paediatrician’s viewpoint. Eur J Pediatr 1997; 156 (12): 899–904

    Article  PubMed  CAS  Google Scholar 

  3. Joint Commission on Immunization and Vaccination. Immunization against infectious disease. London: HM Stationery Office, 1988

    Google Scholar 

  4. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998; 22 (1): 2–14

    Article  PubMed  CAS  Google Scholar 

  5. Maccario R, Chirico G, Mingrat G, et al. Expression of CD45R0 antigen on the surface of resting and activated neonatal T lymphocyte subsets. Biol Neonate 1993; 64 (6): 346–53

    Article  PubMed  CAS  Google Scholar 

  6. Moretta A, Valtorta A, Chirico G, et al. Lymphocyte subpopulations in preterm infants: high percentage of cells expressing P55 chain of interleukin-2 receptor. Biol Neonate 1991; 59 (4): 213–8

    Article  PubMed  CAS  Google Scholar 

  7. Bessler H, Sirota L, Notti I, et al. IL-2 receptor gene expression and IL-2 production by human preterm newborns’ cells. Clin Exp Immunol 1993; 93 (3): 479–83

    Article  PubMed  CAS  Google Scholar 

  8. Kumar A, Jauhari P, Singh U, et al. Quantitation of T cells in venous blood of healthy neonates. Indian J Pediatr 1994; 61 (6): 711–4

    Article  PubMed  CAS  Google Scholar 

  9. Series IM, Pichette J, Carrier C, et al. Quantitative analysis of T and B cell subsets in healthy and sick premature infants. Early Hum Dev 1991; 26 (2): 143–54

    Article  PubMed  CAS  Google Scholar 

  10. Gavin MA, Bevan MJ. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 1995; 3 (6): 793–800

    Article  PubMed  CAS  Google Scholar 

  11. Schroeder Jr HW, Mortari F, Shiokawa S, et al. Developmental regulation of the human antibody repertoire. Ann N Y Acad Sci 1995; 764: 242–60

    Article  PubMed  CAS  Google Scholar 

  12. Veber MB, Cunningham-Rundles S, Schulman M, et al. Acute shift in immune response to microbial activators in very-low-birth-weight infants. Clin Exp Immunol 1991; 83 (3): 391–5

    Article  PubMed  CAS  Google Scholar 

  13. Daum RS, Siber GR, Ballanco GA, et al. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Infect Dis 1991; 164 (6): 1154–9

    Article  PubMed  CAS  Google Scholar 

  14. Barington T, Gyhrs A, Kristensen K, et al. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect Immun 1994; 62 (1): 9–14

    PubMed  CAS  Google Scholar 

  15. Dancis J, Osborn JJ, Kunz HK. Studies of the immunology of the newborn infant. IV Antibody formation in the premature infant. Pediatrics 1953; 12: 151–7

    PubMed  CAS  Google Scholar 

  16. Cates KL, Goetz C, Rosenberg N, et al. Longitudinal development of specific and functional antibody in very low birth weight premature infants. Pediatr Res 1988; 23 (1): 14–22

    Article  PubMed  CAS  Google Scholar 

  17. Bernbaum J, Anolik R, Polin RA, et al. Development of the premature infant’s host defense system and its relationship to routine immunizations. Clin Perinatol 1984; 11 (1): 73–84

    PubMed  CAS  Google Scholar 

  18. Committee on Infectious Diseases, American Academy of Pediatrics. Report of the Committee on Infectious Disease. 19th ed. Evanston (IL): American Academy of Pediatrics, 1982

    Google Scholar 

  19. Vohr BR, Oh W. Age of diphtheria, tetanus, and pertussis immunization of special care nursery graduates. Pediatrics 1986; 77 (4): 569–71

    PubMed  CAS  Google Scholar 

  20. Magoon MW, Belardo LJ, Caldito G. Delays in immunizations of high-risk infants during the first two years of life: special care for the high-risk infant should not mean special immunization schedules. J Perinatol 1995; 15 (3): 222–8

    PubMed  CAS  Google Scholar 

  21. Langkamp DL, Langhough R. Primary care physicians’ knowledge about diphtheria-tetanus-pertussis immunizations in preterm infants. Pediatrics 1992; 89 (1): 52–5

    PubMed  CAS  Google Scholar 

  22. Wilkins J. Immunologic response to various regimens of pertussis vaccine. Fourth Annual Immunization Conference; 1967: San Antonio (TX): U.S. Department of Health, Education and Welfare, 1967: 43–5

  23. Smolen P, Bland R, Heiligenstein E, et al. Antibody response to oral polio vaccine in premature infants. J Pediatr 1983; 103 (6): 917–9

    Article  PubMed  CAS  Google Scholar 

  24. Bernbaum JC, Daft A, Anolik R, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr 1985; 107 (2): 184–8

    Article  PubMed  CAS  Google Scholar 

  25. Conway SP, James JR, Smithells RW, et al. Immunisation of the preterm baby [letter]. Lancet 1987; 2 (8571): 1326

    Article  PubMed  CAS  Google Scholar 

  26. Koblin BA, Townsend TR, Munoz A, et al. Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis J 1988; 7 (10): 704–11

    Article  PubMed  CAS  Google Scholar 

  27. Pullan CR, Hull D. Routine immunisation of preterm infants. Arch Dis Child 1989; 64 (10): 1438–41

    Article  PubMed  CAS  Google Scholar 

  28. Bernbaum J, Daft A, Samuelson J, et al. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants. Pediatrics 1989; 83 (4): 471–6

    PubMed  CAS  Google Scholar 

  29. Conway S, James J, Balfour A, et al. Immunisation of the preterm baby. J Infect 1993; 27 (2): 143–50

    Article  PubMed  CAS  Google Scholar 

  30. D’Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995; 96 (1 Pt 1): 18–22

    PubMed  Google Scholar 

  31. Faldella G, Alessandroni R, Magini GM, et al. The preterm infant’s antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 1998; 16 (17): 1646–9

    Article  PubMed  CAS  Google Scholar 

  32. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996; 334 (6): 341–8

    Article  PubMed  CAS  Google Scholar 

  33. Schloesser RL, Fischer D, Otto W, et al. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999; 103 (5): 60

    Article  Google Scholar 

  34. Committee on Infectious Diseases, American Academy of Pediatrics. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. Pediatrics 1999; 103 (1): 171–2

    Article  Google Scholar 

  35. Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination. MMWR Morb Mortal Wkly Rep 1999; 48 (27): 590

  36. O’Shea TM, Dillard RG, Gillis DC, et al. Low rate of response to enhanced inactivated polio vaccine in preterm infants with chronic illness. Clin Res Regul Affairs 1993; 10 (1): 49–57

    Article  Google Scholar 

  37. Adenyi-Jones SC, Faden H, Ferdon MB, et al. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr 1992; 120 (5): 686–9

    Article  PubMed  CAS  Google Scholar 

  38. Salk J, Stoeckel P, van Wezel AL, et al. Antigen content of inactivated poliovirus vaccine for use in a one-or two-dose regimen. Ann Clin Res 1982; 14 (5–6): 204–12

    PubMed  CAS  Google Scholar 

  39. Hardy Jr GE, Hopkins CC, Linnemann Jr CC, et al. Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules. Pediatrics 1970; 45 (3): 444–8

    PubMed  Google Scholar 

  40. McBean AM, Thoms ML, Albrecht P, et al. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol 1988; 128 (3): 615–28

    PubMed  CAS  Google Scholar 

  41. Faden H, Modlin JF, Thoms ML, et al. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 1990; 162 (6): 1291–7

    Article  PubMed  CAS  Google Scholar 

  42. Washburn LK, TM OS, Gillis DC, et al. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr 1993; 123 (5): 791–4

    Article  PubMed  CAS  Google Scholar 

  43. Munoz A, Salvador A, Brodsky NL, et al. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995; 96 (2 Pt 1): 216–9

    PubMed  CAS  Google Scholar 

  44. Kristensen K, Gyhrs A, Lausen B, et al. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J 1996; 15 (6): 525–9

    Article  PubMed  CAS  Google Scholar 

  45. Kayhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals 1994; 22 (4): 397–402

    Article  PubMed  CAS  Google Scholar 

  46. Madore DV, Johnson CL, Phipps DC, et al. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1-to 6-month-old infants. Pediatrics 1990; 85 (3): 331–7

    PubMed  CAS  Google Scholar 

  47. Santosham M, Hill J, Wolff M, et al. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population [published erratum appears in Pediatr Infect Dis J 1991 May; 10 (5): 369]. Pediatr Infect Dis J 1991; 10 (2): 113–7

    Article  PubMed  CAS  Google Scholar 

  48. Black SB, Shinefield HR, Lampert D, et al. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J 1991; 10 (2): 92–6

    Article  PubMed  CAS  Google Scholar 

  49. Kayhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147 (6): 1100

    Article  PubMed  CAS  Google Scholar 

  50. Decker MD, Edwards KM, Bradley R, et al. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992; 120 (2 Pt 1): 184–9

    Article  PubMed  CAS  Google Scholar 

  51. Chawareewong S, Jirapongsa A, Lokaphadhana K. Immune response to hepatitis B vaccine in premature neonates. Southeast Asian J Trop Med Public Health 1991; 22 (1): 39–40

    PubMed  CAS  Google Scholar 

  52. del Canho R, Grosheide PM, Gerards LJ, et al. Hepatitis B vaccination and preterm infants. Pediatr Infect Dis J 1993; 12 (5): 407–8

    Article  PubMed  Google Scholar 

  53. Belson A, Reif S, Peled Y, et al. Immune response to hepatitis B virus vaccine in 1-year-od preterm and term infants. J Pediatr Gastroenterol Nutr 1996; 23 (3): 252–5

    Article  PubMed  CAS  Google Scholar 

  54. Belloni C, Chirico G, Pistorio A, et al. Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr 1998; 87 (3): 336–8

    Article  PubMed  CAS  Google Scholar 

  55. Blondheim O, Bader D, Abend M, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Childhood Fetal Neonatal Ed 1998; 79 (3): F206–8

    Article  CAS  Google Scholar 

  56. Lau YL, Tam AY, Ng KW, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992; 121 (6): 962–5

    Article  PubMed  CAS  Google Scholar 

  57. Kim SC, Chung EK, Hodinka RL, et al. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics 1997; 99 (4): 534–6

    Article  PubMed  CAS  Google Scholar 

  58. Patel DM, Butler J, Feldman S, et al. Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants. J Pediatr 1997; 131 (4): 641–3

    Article  PubMed  CAS  Google Scholar 

  59. Huang FY, Lee PI, Lee CY, et al. Hepatitis B vaccination in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 77 (2): F135–8

    Article  PubMed  CAS  Google Scholar 

  60. Losonsky GA, Wasserman SS, Stephens I, et al. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics 1999; 103 (2): 14

    Article  Google Scholar 

  61. Golebiowska M, Kardas-Sobantka D, Chlebna-Sokol D, et al. Hepatitis B vaccination in preterm infants. Eur J Pediatr 1999; 158 (4): 293–7

    Article  PubMed  CAS  Google Scholar 

  62. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999; 48 (26): 563–5

    Google Scholar 

  63. Thimerosal in vaccines —an interim report to clinicians. Pediatrics 1999; 104 (3): 570–4

  64. Sedaghatian MR, Hashem F, Moshaddeque Hossain M. Bacille Calmette Guerin vaccination in pre-term infants. Int J Tuberc Lung Dis 1998; 2 (8): 679–82

    PubMed  CAS  Google Scholar 

  65. Sedaghatian MR, Kardouni K. Tuberculin response in preterm infants after BCG vaccination at birth. Arch Dis Child 1993; 69 (3 Spec No): 309–11

    Article  PubMed  CAS  Google Scholar 

  66. Thayyil-Sudhan S, Kumar A, Singh M, et al. Safety and effectiveness of BCG vaccination in preterm babies. Arch Dis Child Fetal Neonatal Ed 1999; 81: F64–6

    Article  PubMed  CAS  Google Scholar 

  67. Groothuis JR, Levin MJ, Lehr MV, et al. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine 1992; 10 (4): 221–5

    Article  PubMed  CAS  Google Scholar 

  68. Rodriguez WJ, Gruber WC, Groothuis JR, et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics 1997; 100 (6): 937–42

    Article  PubMed  CAS  Google Scholar 

  69. Saez-Llorens X, Castano E, Null D, et al. Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group. Pediatr Infect Dis J 1998; 17 (9): 787–91

    Article  PubMed  CAS  Google Scholar 

  70. Thakur BK, Wu LR, Schaeufele JE RSV-IGIV therapy: a cost/benefit analysis [letter]. Pediatrics 1997; 100 (3 Pt 1): 417–8

    Article  PubMed  CAS  Google Scholar 

  71. Botham SJ, Isaacs D, Henderson-Smart DJ. Incidence of apnoea and bradycardia in preterm infants following DTPw and Hib immunization: a prospective study. J Paediatr Child Health 1997; 33 (5): 418–21

    Article  PubMed  CAS  Google Scholar 

  72. Sanchez PJ, Laptook AR, Fisher L, et al. Apnea after immunization of preterm infants. J Pediatr 1997; 130 (5): 746–51

    Article  PubMed  CAS  Google Scholar 

  73. Pourcyrous M, Korones SB, Crouse D, et al. Interleukin-6 C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants. Pediatrics 1998; 101 (3): E3

    Article  PubMed  CAS  Google Scholar 

  74. Topsis J, Kandall S, Weinstein J, et al. Tolerance of initial diphtheria-tetanus-pertussis immunization in preterm infants. J Perinatol 1996; 16 (2 Pt 1): 98–102

    PubMed  CAS  Google Scholar 

  75. Slack MH, Schapira D. Severe apnoeas following immunisation in premature infants. Arch Dis Child Fetal Neonatal Ed 1999; 81: F67–8

    Article  PubMed  CAS  Google Scholar 

  76. Botham SJ, Isaacs D. Incidence of apnoea and bradycardia in preterm infants following triple antigen immunization. J Paediatr Child Health 1994; 30 (6): 533–5

    Article  PubMed  CAS  Google Scholar 

  77. Robinson MJ, Campbell F, Powell P, et al. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999; 80 (1): F69–71

    Article  PubMed  CAS  Google Scholar 

  78. Weinberg GA, Einhorn MS, Lenoir AA, et al. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. J Pediatr 1987; 111 (1): 22–7

    Article  PubMed  CAS  Google Scholar 

  79. Khalak R, Pichichero ME, D’Angio CT. Three-year follow-up of vaccine response in extremely preterm infants. Pediatrics 1998; 101 (4 Pt 1): 597–603

    Article  PubMed  CAS  Google Scholar 

  80. Lieberman JM, Greenberg DP, Wong VK, et al. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 1995; 126 (2): 198–205

    Article  PubMed  CAS  Google Scholar 

  81. Linder N, Yaron M, Handsher R, et al. Early immunization with inactivated poliovirus vaccine in premature infants. J Pediatr 1995; 127 (1): 128–30

    Article  PubMed  CAS  Google Scholar 

  82. Eskola J, Kayhty H. Early immunization with conjugate vaccines. Vaccine 1998; 16 (14–15): 1433–8

    Article  PubMed  CAS  Google Scholar 

  83. Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998; 177 (4): 1112–5

    Article  PubMed  CAS  Google Scholar 

  84. Madore DV. Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy. Pediatr Infect Dis J 1998; 17 (9 Suppl. ): 207S–10S

    Google Scholar 

  85. Daum RS. Efficacy of the combined diphtheria-tetanus toxoids-pertussis-Haemophilus conjugate vaccine. Pediatr Infect Dis J 1995; 14 (7): 640–1

    Article  PubMed  CAS  Google Scholar 

  86. Zepp F, Schmitt HJ, Kaufhold A, et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 1997; 156 (1): 18–24

    Article  PubMed  CAS  Google Scholar 

  87. Sood SK, Ballanco GA, Daum RS. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose. J Pediatr 1991; 119 (4): 652–4

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Strong Children’s Research Center, Department of Paediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA

    Carl T. D’Angio & Caroline B. Hall

Authors
  1. Carl T. D’Angio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline B. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carl T. D’Angio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Angio, C.T., Hall, C.B. Timing of Vaccinations in Premature Infants. BioDrugs 13, 335–346 (2000). https://doi.org/10.2165/00063030-200013050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-200013050-00004

Keywords

Search

Navigation